Carbios SAS set to licence and expand PET recycling
French enzymatic polyethylene therephtalate recycler Carbios SAS has published a licensing documentation for global commercial deployment of its biorecycling technology.
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1125 entries already.
Entries by Thomas Gabrielczyk
Insempra and Axxence launch alpha-ionone
/in News/by Thomas GabrielczykPrecision fermentation specialist Insempra GmbH has inked a supply deal with Axxence Aromatic GmbH for alpha-Ionon, a natural flavour and fragance ingredient.
German-Chinese ADC collaboration
/in News/by Thomas GabrielczykBioNTech has entered the ADC field with an exclusive license and collaboration agreement with Chinas DualityBio Ltd for two antibody-drug conjugate (ADC) assets.
Nomi Biotech presents natural additive to preserve probiotics
/in News/by Thomas GabrielczykResearchers from Polish-Japanese Nomi Biotech sp zoo have presented evidence that that probiotic yogurt can be conserved without artificial preservatives.
LSP Dementia Fund closes at 260m
/in News/by Thomas GabrielczykEQT Life Sciences has closed the LSP Dementia Fund at approximately 260m, 2.6-fold over the target fund size of 100m.
Secarna Pharmaceuticals partners with SciNeuro Pharmaceuticals
/in News/by Thomas GabrielczykAntisense drug developer Secarna Pharmaceuticals and CNS expert SciNeuro Pharmaceuticals have inked an R&D and licence option contract for CNS diseases.
Hot of the press: new issue of BIOTECH Insight
/in News/by Thomas GabrielczykThe latest issue of BIOTECH Insight newsletter of Deutsche Börse in collaboration with BIOCOM AG is out, covering hot topics of the German biotech sector.
Algal enzyme synthesizes gasoline building blocks
/in News/by Thomas GabrielczykAn algal photoenzyme that synthesizes medium-chain hydrocarbons the building blocks of gasoline is set to boost industrial-scale production of biofuels.
Macomics licences macrophage modulator to Ono
/in News/by Thomas GabrielczykEdinburgh-based immuno-oncology expert Macomics Ltd has partnered with Ono Pharmaceutical to develop a macrophage-targeting antibody targetting cancer.
mbiomics GmbH cashes in 13m in Series A financing
/in News/by Thomas GabrielczykMunich-based microbiome therapeutics specialist mbiomics GmbH has raised 13m in the first closing of Series A round led by MIG Capital.